Approval · Notice of Compliance 23536 · 2020
JAMP DIGOXIN: Notice of Compliance 23536
Issued May 4, 2020
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 23536
- Date
- May 4, 2020
- Company
- JAMP Pharma CorporationBoucherville, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Abbreviated New Drug Submission (ANDS)
- Submission class
- Other
- Canadian reference product
- TOLOXIN (Pendopharm Division Of Pharmascience Inc)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| JAMP DIGOXIN | 02498529 | Approved |
| JAMP DIGOXIN | 02498510 | Marketed |
| JAMP DIGOXIN | 02498502 | Marketed |